## Abstract The longβterm efficacy of lamivudine therapy in patients with hepatitis B virus (HBV) infection is still not clear. In this study, 20 nonβcirrhotic Japanese patients infected with HBV received lamivudine therapy for more than 1 year and were followed for a median period of 8.5 years (ra
β¦ LIBER β¦
Favorable long-term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody
β Scribed by Shun-ichi Ariizumi; Yoshihito Kotera; Satoshi Katagiri; Masakazu Yamamoto
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 101 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Favorable efficacy of long-term lamivudi
β
Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Hitomi Sezaki; Tetsuya Hosaka; T
π
Article
π
2005
π
John Wiley and Sons
π
English
β 136 KB
π 1 views
Excellent outcomes with angiographic sub
β
Shozo Iwamoto; Taizo Yamaguchi; Osamu Hongo; Hideki Iwamoto; Hayato Sanefuji
π
Article
π
2010
π
John Wiley and Sons
π
English
β 388 KB
π 2 views
Long-term outcomes of thymosin-Ξ±1 and in
β
Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu
π
Article
π
2003
π
John Wiley and Sons
π
English
β 179 KB
π 1 views
Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and
Analysis of factors affecting the appear
β
Yoshio Aizawa; Yuka Shibamoto; Ichiro Takagi; Mikio Zeniya; Gotaro Toda
π
Article
π
2000
π
John Wiley and Sons
π
English
β 97 KB
π 3 views
P48 is a predictive marker for outcome o
β
Yong-Bing Qian; Ju-Bo Zhang; Wei-Zhong Wu; Hong-Bin Fang; Wei-Dong Jia; Peng-Yua
π
Article
π
2006
π
John Wiley and Sons
π
English
β 224 KB
π 1 views